title: Another face of Kawasaki disease.
abstract: We aimed both to define the characteristics of patients with Kawasaki Disease (KD), and to highlight infrequent and unusual findings of the disease by presenting selected cases. We retrospectively evaluated 35 patients diagnosed with KD in our clinic between January 1994 and January 2013. The male to female ratio was 1.33 and the median age at admission was 22 months (1.5-132 months). Fourteen patients (40%) had coronary artery lesions (CAL). Twenty-five cases (72%) had complete and 10 cases (28%) had incomplete KD; the incidence of CAL in these groups was 36% and 50%, respectively. Two patients had giant coronary aneurysms. Six cases received a second dose of intravenous immunoglobulin, and one patient received pulse methylprednisolone. Seven cases had unusual and/or infrequent presentation patterns and/or follow-up. Physicians should be aware of all symptoms and laboratory findings of KD in order to avoid any delays in diagnosis and decrease the risk of life-threatening complications.
authors.affiliation: Division of Pediatric Infectious Diseases, Ankara University, Faculty of Medicine, Ankara, Turkey. drbaldemir@yahoo.com.
authors.forename: Bilge
authors.initials: B
authors.lastname: Aldemir-Kocabaş
authors.forename: Adem
authors.initials: A
authors.lastname: Karbuz
authors.forename: Cem
authors.initials: C
authors.lastname: Karadeniz
authors.forename: Ömer
authors.initials: Ö
authors.lastname: Çiftçi
authors.forename: Halil
authors.initials: H
authors.lastname: Özdemir
authors.forename: Musa Gökalp
authors.initials: MG
authors.lastname: Bolkent
authors.forename: Tayfun
authors.initials: T
authors.lastname: Uçar
authors.forename: Ercan
authors.initials: E
authors.lastname: Tutar
authors.forename: Semra
authors.initials: S
authors.lastname: Atalay
authors.forename: Suat
authors.initials: S
authors.lastname: Fitöz
authors.forename: Ergin
authors.initials: E
authors.lastname: Çiftçi
authors.forename: Erdal
authors.initials: E
authors.lastname: İnce
mesh_terms: D000328:Adult; D002648:Child; D002675:Child, Preschool; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D015994:Incidence; D007223:Infant; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use*; D009080:Mucocutaneous Lymph Node Syndrome / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy; D012189:Retrospective Studies; D014421:Turkey / Q000453:epidemiology
chemical_list: D005938:Glucocorticoids; D016756:Immunoglobulins, Intravenous; D008775:Methylprednisolone